Polymorphisms in the gene encoding adiponectin receptor 1 (AdipoR1) are associated with insulin resistance, fatty liver, increased risk for type 2 diabetes and cardiovascular disease. AdipoR1 is expressed in the central nervous system and in the olfactory mucosa of mice and humans. We therefore hypothesized that a common polymorphism in AdipoR1 might alter olfactory function. We investigated a group of 222 healthy subjects (male: n ¼ 147, female: n ¼ 75) for olfactory recognition, and genotyped them for the polymorphism rs6666089 in the human AdipoR1 gene. This polymorphism has been previously shown to be associated with insulin resistance. Olfactory recognition was tested using standardized sniffing sticks, and parameters of glucose metabolism and serum adiponectin levels were assessed. We found a significant olfactory impairment in carriers of the AdipoR1 polymorphism rs6666089 (olfactory recognition: GG: 89.4 ± 1.2%, GA: 86.9 ± 1.4%, AA: 77.2 ± 4.8%, additive model, P ¼ 0.0004, adjusted for age). Adiponectin levels had no impact on olfactory recognition. Fasting plasma glucose, fasting plasma insulin, body mass index and HbA1c did not differ between the genotype groups. In conclusion, the presence of a genetic variation in AdipoR1 is associated with decreased olfactory recognition in healthy subjects. Adiponectin signalling may have an important role in olfactory function and regulation of appetite.
Introduction
Adiponectin, an adipokine mainly produced by white and brown adipose tissue, was first described in 1995. 1 It circulates in high concentrations in blood and, despite being produced by adipose tissue, adiponectin serum levels decrease in individuals with obesity. 2 Increased adiponectin levels are associated with increased insulin sensitivity, protection against type 2 diabetes mellitus, reduced inflammation and antiatherogenic effects. 3, 4 Adiponectin functions via two adiponectin receptors, adiponectin receptor 1 and 2 (AdipoR1 and AdipoR2), which were discovered in 2003. 5 Both receptors consist of seven transmembrane domain proteins and have been structurally conserved from yeast to humans. In mice, AdipoR1 is mainly expressed in the skeletal muscle, where it promotes lipid oxidation, whereas AdipoR2 is expressed in the liver, where it increases insulin sensitivity. 5, 6 In humans, the highest mRNA levels for both receptors were found in skeletal muscle. 5 High insulin levels were shown to reduce the expression of both receptors 7 and thereby reduce adiponectin function.
The human gene encoding AdipoR1 is located on chromosome 1 (q32.1) and consists of 17 Kbp. A total of 28 singlenucleotide polymorphisms exist in the AdipoR1 gene, and their effects on several metabolic traits have been investigated. The findings of these studies are inconsistent; some studies found an association with insulin resistance and type 2 diabetes, whereas others did not. 8 Our group recently described a common polymorphism in the promoter region of AdipoR1 located 8503 bp upstream of the translational start codon (rs6666089; minor allele frequency 0.267), which was linked to lower insulin sensitivity, higher HbA1 and higher liver fat in a European population. 9 Adipokines function not only in the periphery but also in the central nervous system: adiponectin is found in the cerebrospinal fluid of rodents and humans. [10] [11] [12] Furthermore, AdipoR1 and AdipoR2 are expressed in the hypothalamus. 10 Adiponectin takes part in the regulation of food intake through AdipoR1 and subsequent phosphorylation of AMP-activated protein kinase in the hypothalamus. 6 Under starvation conditions, adiponectin levels are increased and lead to an increased AMP-activated protein kinase activation and to increased food intake. Refeeding leads to a suppression of AMP-activated protein kinase phosphorylation. 6 Therefore, adiponectin functions as an orexigenic hormone that controls energy homeostasis. Recently, AdipoR1 was shown to be expressed in the olfactory mucosa of mice. 13 The chemosensory system has a role in food intake regulation, as the smell of food affects metabolic parameters and food intake. 14 On the other hand, disturbances in glucose metabolism and diabetes alter olfactory function. 15 The expression of AdipoR1 in olfactory mucosa intrigued us to further assess the role of adiponectin in energy homeostasis, especially with regard to the chemosensory system. We therefore genotyped healthy Caucasians for a common polymorphism (À8503 G/A) in the promoter region of AdipoR1 and investigated their olfaction capacity. Furthermore, we assessed glucose metabolism, as adiponectin function was shown to be linked to glucose metabolism and insulin sensitivity. We hypothesized that genetic variation in AdipoR1 influences olfactory function.
Materials and methods

Subjects
Our study group consisted of subjects who had participated in the PRIPS Study (Prospective validation of risk markers for the idiopathic Parkinson syndrome) in the Department of Neurodegeneration in Tubingen. The subjects were healthy Caucasians from southern Germany, aged between 51 and 82 years. They were recruited either by advertisement in local newspapers or from local companies to take part in a prospective longitudinal study evaluating risk factors for the development of Parkinson's disease. Out of 812 subjects taking part in this ongoing study, we selected subjects who had both olfactory testing and complete blood sampling. Blood was collected after an overnight fast. It was later analysed for glucose, insulin, HbA1c and adiponectin, as well as for DNA (see Analytical measurements section for details). Exclusion criteria were as follows: infection of the upper airway tract, allergies, diabetes mellitus, Parkinson's disease, Alzheimer's disease or HbA1c X8%, as an indicator of an impaired glycemic metabolic status. Subjects were questioned about their current medication; any subjects taking medication were excluded from our study. Therefore, 222 subjects were included in our study and genotyped for the rs6666089 polymorphism in the AdipoR1 gene. The anthropometric characteristics of the study population are shown in Table 1 . Informed written consent was obtained from all participants and the local Ethics Committee approved the protocol.
Olfactory testing
The 12-sticks odour identification test (Burghart medical technics, Weden, Germany) was used for olfactory testing. This test had been developed as a short version of the odour identification test of the 'Sniffin Sticks' test battery, which was developed by Hummel and Kobal. 16, 17 The whole battery comprises of 120 'Sniffing Sticks' that are designed to test for odour detection, odour discrimination and odour detection thresholds. Significant separation of normosmic and anosmic subjects has been shown for all parts of the battery, as well as a good correlation with the University of Pennsylvania Smell Identification Test (UPSIT). 18 A good identification of normosmic and hyposmic/anosmic subjects has also been shown for the 12-sticks odour identification test. 19 To achieve reliable results, the sticks were used in a standardized manner. They were consecutively placed in front of the nostrils of the participants for up to 30 s. The investigator named four possibilities for each odour, from which the subject had to choose. Olfactory recognition was measured as a percentage of maximum smell detection. A value o75% was considered as pathological olfactory recognition, according to Hummel et al.
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Analytical measurements
Venous plasma glucose was measured using a bedside glucose analyser (glucose oxidase method, Yellow Springs Instruments, Yellow Springs, OH, USA); plasma insulin was determined by microparticle enzyme immunoassay (Abbott Laboratories, Tokyo, Japan). HbA1c was measured using the Tosoh HLC-723 (GHbV) A1c2.2 analyser (Tosho Corporation, Tokyo, Japan). Adiponectin levels were measured by ELISA (LINCO Research, St Charles, MO, USA). DNA was isolated from whole blood using a commercial DNA isolation kit (NucleoSpin, Macherey & Nagel, Germany). The above-mentioned single-nucleotide polymorphism was genotyped using the TaqMan assay (Applied Biosystems, Foster City, CA, USA). The TaqMan genotyping reaction was amplified on a GeneAmp PCR system 7000 (50 1C for 10 min, 95 1C for 10 min, 92 1C for 15 s, 60 1C for 1 min for 35 cycles), and fluorescence was detected on an ABI Prism 7000 sequence detector (Applied Biosystems).
Calculation
Insulin sensitivity was calculated using the homeostatic model assessment-insulin resistance method (HOMA-IR), in which insulin level (pmol l À1 ) was multiplied with glucose level (mmol l
À1
) and then divided by 135.
Statistical analysis
All data are given as unadjusted mean ± s.e.m. Abnormally distributed parameters were log transformed to approximate normal distribution before statistical analysis. Differences in parameters between genotypes were tested using a multivariate linear regression model. Results with values of Pp0.05 were considered statistically significant. The JMP 7.0 (SAS Institute, Cary, NC, USA) statistical software package was used.
Results
We examined 222 healthy subjects, 147 males and 75 females. Their mean age was 62.0 ± 0.5 and their mean body mass index was 26.6±0.3 kg m
À2
. The mean olfactory recognition was 87.3±1.0%, and 27 out of the 222 subjects had a pathological olfactory recognition, defined as an olfactory recognition o75%.
The distribution of genotypes was in Hardy-Weinberg equilibrium. Olfactory recognition was significantly impaired in carriers of the À8503 G/A polymorphism (GG: 89.4 ± 1.2% (n ¼ 111), GA: 86.9±1.4% (n ¼ 92), AA: 77.2±4.8% (n ¼ 19), P ¼ 0.0004, additive model, adjusted for age, Table 1 ). Adiponectin levels had no impact on olfactory recognition (P ¼ 0.14, adjusted for age). Gender also had no impact on olfactory recognition (P ¼ 0.17, adjusted for age). In addition, we found no interaction effect of gender and À8503 G/A genotype on olfactory recognition (P ¼ 0.24). Furthermore, olfactory function was not associated with insulin sensitivity (P ¼ 0.66).
Fasting plasma glucose, fasting plasma insulin, HbA1c, body mass index and gender did not differ between genotype groups. There was no effect of the À8503 G/A polymorphism on HOMA-IR (all P40.2; Table 1 ).
As expected, adiponectin levels were significantly associated with HOMA-IR (P ¼ 0.0003, data not shown).
Discussion
In this study, we demonstrated that carriers of the À8503 G/A polymorphism in the promoter of the human AdipoR1 gene exhibit a potent impairment in olfactory recognition.
Adiponectin is one of the key hormones in the regulation of energy homeostasis. It enhances, via AdipoR1, AMP-activated protein kinase activity in the hypothalamus, thereby increasing food intake and decreasing energy expenditure. 6 Hass et al. 13 showed that AdipoR1 is also expressed in the olfactory mucosa of mice, indicating a linkage between adiponectin and olfaction. The finding that a genetic variation in AdipoR1 is linked to olfactory function suggests an influence of adiponectin function on the chemosensory system, with possible effects on the regulation of hunger and food intake. This is in accordance with animal studies showing an increased sensitivity of the olfactory system during starvation. 21 The potential role of adiponectin in energy homeostasis is strengthened by the results of Guillod-Maximin et al., 22 who showed that adiponectin receptors are expressed in a neuronal population producing both orexigenic neuropeptide Y and anorexigenic proopiomelanocortin.
We have previously shown that genetic variation in Kv1.3 is linked to olfactory function. 23 Kv1.3 is a voltage-gated potassium channel that is also involved in glucose homeostasis and weight control in both mice and men. 24 Therefore, glucose metabolism and olfactory function seem to be linked. In this study we also showed that lipid metabolism is linked to olfaction via the adiponectin receptor as part of the adiponectin signalling. Therefore, olfaction might have a major role in metabolism and energy regulation in general, even though precise mechanisms are still unclear. Stefan et al. 9 showed that the 8503 G/A variant in human
AdipoR1 is associated with lower insulin sensitivity, higher HbA1c and higher liver fat. In the population of the present study, we could not detect an effect of this polymorphism on glucose metabolism and insulin sensitivity; however, the number of investigated subjects (n ¼ 222) is too small to detect such subtle effects. Furthermore, we assessed insulin resistance by using the homeostasis model (HOMA-IR). While the hyperinsulinaemic euglycaemic clamp is considered the gold standard for measurement of peripheral insulin sensitivity and largely represents insulin sensitivity of the skeletal muscle, HOMA-IR may not be accurate enough to detect a weak single-nucleotide polymorphism effect on insulin sensitivity. However, we did confirm the well-known association of adiponectin levels and insulin sensitivity. We have to acknowledge some limitations of the present study: (1) We used the commonly used 12 sniffing sticks for Genetic variation in AdipoR1 affects olfaction M Guthoff et al odour identification. Time-consuming tests for threshold detection and odourant habituation trials would have yielded more detailed results about olfactory function. As we excluded subjects with dementia from this cohort, it seems unlikely that group differences are due to impaired cognitive performance. However, we did not control for mild cognitive deterioration in this study. From daily application, we are confident that mild cognitive symptoms hardly affect the very easy and quick sniffing-sticks test. It is still important to investigate the exact influence of cognition on olfactory function in relation to the genetic variation in AdipoR1 in further studies. (2) Olfactory testing was performed only in the fasting state. It would be interesting to test the effect on olfaction both in fasting and non-fasting condition. (3) We only investigated the effects of the singlenucleotide polymorphism rs6666089 in AdipoR1 for which no functional data are available up to now. Therefore, it might be just a marker for some other risk factor. However, we wanted to test the specific hypothesis that this variant, which in our study group has been shown previously to be associated with insulin resistance and fatty liver, impairs olfactory function. The effect of other components of adiponectin signalling on olfactory function might be an interesting topic for further investigation.
In conclusion, we showed that a genetic variation in the promotor of AdipoR1 is linked to olfactory recognition. Adiponectin signalling may therefore have an important role in the regulation of appetite and energy homeostasis.
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